Elevance Health CEO and director buy $1.37M in open-market stock purchases
Gail Boudreaux, president and CEO of Elevance Health, and director Ramiro G Peru purchased shares on July 17, 2026, in open-market transactions. Boudreaux acquired 2,725 shares for $1.002M across two purchases (680 shares at weighted average $366.41 and 2,045 shares at weighted average $368.25), while Peru bought 1,000 shares at $366.05. The aggregate value of all reported acquisitions was $1.37M.
Key facts
- Gail Boudreaux (President and CEO) purchased 2,725 shares for $1.002M on 2026-07-17
- Ramiro G Peru (director) purchased 1,000 shares at $366.05 on 2026-07-17
- aggregate value of all reported acquisitions: $1.37M
- Boudreaux's first purchase: 680 sh @ $366.41 weighted average
- Boudreaux's second purchase: 2,045 sh @ $368.25 weighted average
- first purchase executed at prices ranging from $366.14 to $366.48
- second purchase executed at prices ranging from $367.76 to $368.69
Why it matters
Open-market purchases by the CEO and a director, without 10b5-1 plans, signal insider confidence in Elevance Health's near-term stock performance.
Share
Derived from 4 filed 2026-07-17. Not investment advice. View the source filing on SEC.gov →